The way we deliver medicine is changing faster than ever before. With more than 900 ATMP companies worldwide innovating new products, this wave of personalized medicine is about to make landfall and disrupt an industry built on mass scale-up capabilities. This forum will share real time information about what’s going on in the industry, including the latest technologies, standards, industry guidelines, and case studies of those leading the way in this space.
All Levels. Whether you are new to the industry and want to gain an understanding of Advanced Therapy Medicinal Products (ATMP), or a seasoned professional, this will be an exciting forum with the latest information available on this very hot topic.
Gilead Sciences, Inc.
4100 Avenida de la Plata
Oceanside, CA CA, 92056
Anthony Davies, PhD, Founder & CEO, Dark Horse Consulting Inc.
Nicki Lange, Director of Business Development, CRB
Lei Shi, VP Global Manufacturing, Kite Pharma, a Gilead
Xiao-Ping Dai, PhD, VP, C> Process Development, Chief Technologist,
WuXi Advanced Therapies
Joan Haab, Site Head, Gene Therapy Operations, MilliporeSigma
Peter Walters, ATMP Subject Matter Expert, CRB
Emilie Pelletier, USA Managing Partner, LAPORTE Consultants Corp
Erin Rasch, MS, Senior Director, Be The Match BioTherapies®
Noel Maestre, Biotech Team Lead, CRB (Moderator)
Leo Castaneda, President/CEO, AES (Automation Engineering Systems)
Ken Rando, Director of Business Development, BioSpherix Medical
Fred Koller, Executive VP, Miltenyi Biotec
Eytan Abraham, VP of Personalized Medicine, Lonza
David Keggan, Sales Engineer, Comecer